Health Catalyst Full Year 2024 Earnings: EPS Misses Expectations
Revenue: US$306.6m (up 3.6% from FY 2023).
Net loss: US$69.5m (loss narrowed by 41% from FY 2023).
US$1.16 loss per share (improved from US$2.09 loss in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%.
The primary driver behind last 12 months revenue was the Technology segment contributing a total revenue of US$194.9m (64% of total revenue). Notably, cost of sales worth US$164.8m amounted to 54% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Research & Development (R&D) costs, amounting to US$56.8m (27% of total expenses). Explore how HCAT's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 8.9% p.a. on average during the next 3 years, compared to a 9.7% growth forecast for the Healthcare Services industry in the US.
Performance of the American Healthcare Services industry.
The company's shares are down 6.8% from a week ago.
We don't want to rain on the parade too much, but we did also find 2 warning signs for Health Catalyst that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Atlantic
29 minutes ago
- Atlantic
The Senator Who Failed America on Vaccines
It's easy to forget that Robert F. Kennedy Jr.'s assault on vaccines—including, most recently, his gutting of the expert committee that guides American vaccine policy—might have been avoided. Four months ago, his nomination for health secretary was in serious jeopardy. The deciding vote seemed to be in the hands of one Republican senator: Bill Cassidy of Louisiana. A physician who gained prominence by vaccinating low-income kids in his home state, Cassidy was wary of the longtime vaccine conspiracist. 'I have been struggling with your nomination,' he told Kennedy during his confirmation hearings in January. Then Cassidy caved. In the speech he gave on the Senate floor explaining his decision, Cassidy said that he'd vote to confirm Kennedy only because he had extracted a number of concessions from the nominee—chief among them that he would preserve, 'without changes,' the very CDC committee Kennedy overhauled this week. Since then, Cassidy has continued to give Kennedy the benefit of the doubt. On Monday, after Kennedy dismissed all 17 members of the vaccine advisory committee, Cassidy posted on X that he was working with Kennedy to prevent the open roles from being filled with 'people who know nothing about vaccines except suspicion.' The senator has failed, undeniably and spectacularly. One new appointee, Robert Malone, has repeatedly spread misinformation (or what he prefers to call 'scientific dissent') about vaccines. Another appointee, Vicky Pebsworth, is on the board of an anti-vax nonprofit, the National Vaccine Information Center. Cassidy may keep insisting that he is doing all he can to stand up for vaccines. But he already had his big chance to do so, and he blew it. Now, with the rest of America, he's watching the nation's vaccine future take a nosedive. So far, the senator hasn't appeared interested in any kind of mea culpa for his faith in Kennedy's promises. On Thursday, I caught Cassidy as he hurried out of a congressional hearing room. He was still reviewing the appointees, he told me and several other reporters who gathered around him. When I chased after him down the hallway to ask more questions, he told me, 'I'll be putting out statements, and I'll let those statements stand for themselves.' A member of his staff dismissed me with a curt 'Thank you, sir.' Cassidy's staff has declined repeated requests for an interview with the senator since the confirmation vote in January. With the exception of Mitch McConnell, every GOP senator voted to confirm Kennedy. They all have to own the health secretary's actions. But Cassidy seemed to be the Republican most concerned about Kennedy's nomination, and there was a good reason to think that the doctor would vote his conscience. In 2021, Cassidy was one of seven Senate Republicans who voted to convict Donald Trump on an impeachment charge after the insurrection at the Capitol. But this time, the senator—who is up for reelection next year, facing a more MAGA-friendly challenger—ultimately fell in line. Cassidy tried to have it both ways: elevating Kennedy to his job while also vowing to constrain him. In casting his confirmation vote, Cassidy implied that the two would be in close communication, and that Kennedy had asked for his input on hiring decisions. The two reportedly had breakfast in March to discuss the health secretary's plan to dramatically reshape the department. 'Senator Cassidy speaks regularly with secretary Kennedy and believes those conversations are much more productive when they're held in private, not through press headlines,' a spokesperson for Cassidy wrote in an email. (A spokesperson for HHS did not immediately respond to a request for comment.) At times, it has appeared as though Cassidy's approach has had some effect on the health secretary. Amid the measles outbreak in Texas earlier this year, Kennedy baselessly questioned the safety of the MMR vaccine. In April, after two unvaccinated children died, Cassidy posted on X: 'Everyone should be vaccinated! There is no treatment for measles. No benefit to getting measles. Top health officials should say so unequivocally b/4 another child dies.' Cassidy didn't call out Kennedy by name, but the health secretary appeared to get the message. Later that day, Kennedy posted that the measles vaccine was the most effective way to stave off illness. ('Completely agree,' Cassidy responded.) All things considered, that's a small victory. Despite Kennedy's claims that he is not an anti-vaxxer, he has enacted a plainly anti-vaccine agenda. Since being confirmed, he has pushed out the FDA's top vaccine regulator, hired a fellow vaccine skeptic to investigate the purported link between autism and shots, and questioned the safety of childhood vaccinations currently recommended by the CDC. As my colleague Katherine J. Wu wrote this week, 'Whether he will admit to it or not, he is serving the most core goal of the anti-vaccine movement—eroding access to, and trust in, immunization.' The reality is that back channels can be only so effective. Cassidy's main power is to call Kennedy before the Senate health committee, which he chairs, and demand an explanation for Kennedy's new appointees to the CDC's vaccine-advisory committee. Cassidy might very well do that. In February, he said that Kennedy would 'come before the committee on a quarterly basis, if requested.' Kennedy did appear before Cassidy's committee last month to answer questions about his efforts to institute mass layoffs at his agency. Some Republicans (and many Democrats) pressed the secretary on those efforts, while others praised them. Cassidy, for his part, expressed concerns about Kennedy's indiscriminate cutting of research programs, but still, he was largely deferential. 'I agree with Secretary Kennedy that HHS needs reform,' Cassidy said. Even if he had disagreed, an angry exchange between a health secretary and a Senate committee doesn't guarantee any policy changes. Lawmakers may try to act like government bureaucrats report to them, but they have limited power once a nominee is already in their job. Technically, lawmakers can impeach Cabinet members, but in American history, a sitting Cabinet member has never been impeached and subsequently removed from office. The long and arduous confirmation process is supposed to be the bulwark against potentially dangerous nominees being put in positions of power. Cassidy and most of his Republican colleagues have already decided not to stop Kennedy from overseeing the largest department in the federal government by budget. Now Kennedy is free to do whatever he wants—senators be damned.
Yahoo
31 minutes ago
- Yahoo
Ram Brand Launches 'Never Stop Being American' Marketing Campaign, New Brand Ethos 'Nothing Stops Ram'
"Never Stop Being American" marketing campaign takes off across broadcast and Ram brand's social media channels Campaign celebrates America, its people, pastimes and traditions, formally introduces the Ram brand's new tagline, "Nothing Stops Ram" Set to a custom version of "The Star-Spangled Banner" by Kenny Wayne Shepherd, the spot launches on Flag Day UFC's Dana White narrates the Ram brand anthem Launch follows on the heels of brand's recent announcements that the HEMI® V-8 has returned to Ram and Ram brand is back in NASCAR Ram brand to take part in America250 yearlong celebration as exclusive truck sponsor AUBURN HILLS, Mich. , June 14, 2025 /PRNewswire/ -- It's not the 4th of July yet, but the Ram brand is already setting off the fireworks! On the heels of the brand's highly anticipated and long-awaited news that the HEMI® V-8 is making a comeback and that Ram brand is back in NASCAR, Ram is launching its new marketing campaign, "Never Stop Being American," and with it, even more attitude with the brand's new tagline, "Nothing Stops Ram." "Never Stop Being American" screams red, white and blue. Set to a custom version of "The Star-Spangled Banner" by Kenny Wayne Shepherd and narrated by UFC's Dana White, the 60-second spot, launching on Flag Day, explodes with fireworks, HEMI V-8s, NASCAR, tattooed grandmas, rodeos, burnouts, the Goodyear Blimp, the Ram Monster Truck, Ram trucks and fighter jets with patriotic smoke trails, mullets and blue suede shoes, just to name a few."Ram's new campaign, 'Never Stop Being an American,' is an ode to America, its people, its culture and time-honored traditions," said Olivier Francois, global chief marketing officer, Stellantis. "Launching it, and the new 'Nothing Stops Ram' tagline, sets the stage for an epic year for the brand that will be remembered for the HEMI V-8's comeback and return to NASCAR and, for the country, leading into America's 250th anniversary, in which Ram will play a leading role during the yearlong celebration as the event's exclusive truck partner." The news of the HEMI V-8 and NASCAR return was officially announced by Tim Kuniskis, global CEO of the Ram brand, during a live NASCAR event at the Michigan International Speedway on June 8."Last weekend, we let our Ram customers know that we heard them loud and clear, and the HEMI V-8 is back," said Kuniskis. "Nothing stops Americans, and nothing stops Ram, so when our drivers told us what they wanted in their trucks, we answered the call. This is just the start of what will be an unforgettable year for the brand and for our customers, which starts now by giving them what they've fought us to have, freedom of choice that includes the return of an iconic American powertrain." The "Never Stop Being American" marketing campaign was created in partnership with the Ram brand and Glue IQ, with Doner developing the "Nothing Stops Ram" tagline. Ram brand also launched its "Ram-Demption" campaign as part of last weekend's events at Michigan International Speedway, officially signaling the return of the HEMI V-8 and the brand's return to NASCAR. The 68-second video features Kuniskis behind the wheel of Ram's NASCAR concept truck at Darlington Raceway in South Carolina, with the iconic Goodyear Blimp and jets flying overhead. Different versions of the "Ram-Demption" video include 60-, 30- and 15-second spots, which are running across NASCAR media and the Ram brand's social media channels, in addition to a long-form video running on the Ram brand's YouTube channel. "Ram-Demption" was created in partnership with Argonaut agency. The Ram brand will also play a big part in the festivities surrounding the 250th anniversary of America, announcing its exclusive truck brand partnership with America250, the bipartisan organization charged by Congress to lead the commemoration of the signing of the Declaration of Independence. The Ram brand will also play a big part in the festivities surrounding the 250th anniversary of America, announcing its exclusive truck brand partnership last month with America250, the bipartisan organization charged by Congress to lead the commemoration of the signing of the Declaration of Independence. Ram brand will play a central role in the yearlong celebration, which includes providing trucks that move America250 official events across the country​. In addition, the Ram brand will reveal a limited-edition A250 vehicle within its truck portfolio to commemorate the yearlong celebration. More details will be announced as the celebration continues throughout the brand's parent company, formerly named after Walter P. Chrysler, celebrated its 100th anniversary on June 6, 2025. Ram BrandRam offers a full lineup of pickups and commercial vehicles; the Ram 1500, 2500/3500 Heavy Duty, 3500/4500/5500 Chassis Cab and ProMaster Ram Light-Duty and Heavy Duty pickups are considerably improved for 2025 and offer new products in the fastest growing segment within the pickup space—Sport Trucks. Ram introduced the largest variety of off-road performance trucks the brand has ever offered, including the new Ram 1500 RHO with more horsepower per dollar than any other performance off-road the commercial business, Ram is launching the new 2025 Chassis Cab line with improvements to help customers and upfitters. Ram Professional is making considerable changes in process, execution and resources with a focus on commercial offerings, dedicated B2B-focused expertise, and sales and service support, which are critical to growing in this continues to outperform the competition, setting the benchmark in the most important areas for truck buyers: Segment-first: 1,000 lb.-ft of torque with Cummins Turbo Diesel Most luxurious: Ram 1500 Tungsten with air suspension, 24-way massage seats and 540 horsepower Ram 1500 and Heavy Duty: Best ride and handling with five-link solid rear axle with available, segment-exclusive, active-level air suspension Ram 1500 RHO: Best off-road performance per dollar Ram ProMaster: The most cargo space available in any traditional full size cargo van Ram Power Wagon: Most off-road capable full-size pickup Ram is improving market competitiveness and growth while maintaining pricing power through products, services and electrified offerings. Aligned under the global presence of the Stellantis Pro One commercial vehicle organization, Ram currently offers a wide range of products globally, from the Ram 700 compact pickup to the Ram 5500 Chassis Cab and a range of ProMaster is part of the portfolio of brands offered by leading global automaker and mobility provider Stellantis. For more information regarding Stellantis (NYSE: STLA), please visit Follow Ram and company news and video on:Company blog: website: Truck brand: @RamTrucks, @StellantisNAYouTube: For more information, please visit the Stellantis media site for North America at View original content to download multimedia: SOURCE Stellantis Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
33 minutes ago
- Yahoo
One Booz Allen Hamilton Holding Insider Raised Their Stake In The Previous Year
Insiders were net buyers of Booz Allen Hamilton Holding Corporation's (NYSE:BAH ) stock during the past year. That is, insiders bought more stock than they sold. While insider transactions are not the most important thing when it comes to long-term investing, we do think it is perfectly logical to keep tabs on what insiders are doing. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. The Independent Director Joan Lordi Amble made the biggest insider purchase in the last 12 months. That single transaction was for US$294k worth of shares at a price of US$147 each. That means that even when the share price was higher than US$103 (the recent price), an insider wanted to purchase shares. While their view may have changed since the purchase was made, this does at least suggest they have had confidence in the company's future. To us, it's very important to consider the price insiders pay for shares. It is encouraging to see an insider paid above the current price for shares, as it suggests they saw value, even at higher levels. Joan Lordi Amble was the only individual insider to buy shares in the last twelve months. Joan Lordi Amble purchased 3.62k shares over the year. The average price per share was US$143. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below! View our latest analysis for Booz Allen Hamilton Holding There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of undervalued small cap companies that insiders are buying. Many investors like to check how much of a company is owned by insiders. We usually like to see fairly high levels of insider ownership. It's great to see that Booz Allen Hamilton Holding insiders own 1.6% of the company, worth about US$209m. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders. There haven't been any insider transactions in the last three months -- that doesn't mean much. On a brighter note, the transactions over the last year are encouraging. It would be great to see more insider buying, but overall it seems like Booz Allen Hamilton Holding insiders are reasonably well aligned (owning significant chunk of the company's shares) and optimistic for the future. So these insider transactions can help us build a thesis about the stock, but it's also worthwhile knowing the risks facing this company. Our analysis shows 3 warning signs for Booz Allen Hamilton Holding (1 is a bit unpleasant!) and we strongly recommend you look at these before investing. But note: Booz Allen Hamilton Holding may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt. For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
